Blachman Amir 4
4 · Targeted Medical Pharma, Inc. · Filed Nov 29, 2012
Insider Transaction Report
Form 4
Blachman Amir
VP of Strategy and Operations
Transactions
- Exercise/Conversion
Common Stock
2012-11-12$3.38/sh+2,396$8,098→ 2,396 total - Tax Payment
Common Stock
2012-11-12$5.00/sh−54,986$274,930→ 26,354 total - Exercise/Conversion
Options to Purchase Common Stock
2012-11-12−7,395→ 0 totalExercise: $3.38From: 2010-05-16Exp: 2020-05-16→ Common Stock (7,395 underlying) - Exercise/Conversion
Options to Purchase Common Stock
2012-11-12−73,945→ 0 totalExercise: $3.38Exp: 2020-07-28→ Common Stock (73,945 underlying) - Exercise/Conversion
Common Stock
2012-11-12$3.38/sh+23,958$80,978→ 23,958 total
Footnotes (1)
- [F1]These options vested on a monthly basis in equal installments over a two-year period beginning 07/28/2012